Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Access Pharmaceuticals, Inc.
(OP:
ACCP
)
0.5200
USD
+0.0500 (+10.64%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
39,730
Open
0.4700
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.4700
Today's Range
0.4500 - 0.5200
52wk Range
0.2100 - 0.8000
Shares Outstanding
24,732,312
Dividend Yield
N/A
Top News
More News
Access Pharmaceuticals Reports First Quarter Results
May 16, 2013
MuGard Gross Revenues Up 118% Quarter-on-Quarter and Over 20% from Q4 2012
Read More
from
PR Newswire
Rush University Medical Center Presents Positive MuGard Clinical Data at the Oncology Nursing Society 38th Annual Congress
April 29, 2013
128 Patient MuGard Study Underscores the Powerful Clinical Impact MuGard Provides Cancer Patients Suffering with Oral Mucositis
Read More
from
PR Newswire
More News
Read More
Access Pharmaceuticals To Host Fourth Quarter And Fiscal Year Investor Call On Wednesday, April 3rd At 11:00am ET
March 20, 2013
from
PR Newswire
Access Pharmaceuticals To Host Third Quarter Investor Call on Wednesday, November 28th
November 15, 2012
from
PR Newswire
Access Pharmaceuticals Announces Private Placement Financing
October 25, 2012
from
PR Newswire
Access Pharmaceuticals To Host Second Quarter Investor Call on Thursday, August 23, 2012
August 17, 2012
from
PR Newswire
Access Pharmaceuticals Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium
June 28, 2012
from
PR Newswire
Access Pharmaceuticals to Report New MuGard Clinical Trial Data This Week at the MASCC/ISOO Symposium in New York City
June 26, 2012
from
PR Newswire
Access Pharmaceuticals To Host Investor Call On Wednesday, May 23, 2012
May 17, 2012
from
PR Newswire
UPDATE: 9th Annual Taglich Brothers Small Cap Equity Conference
April 23, 2012
from
Marketwired News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here